RE: Sage, Edward, sang14 Jun 2022 15:25
That situation is very different in my view. Prior to Covid, whilst the technology market was doing well, it was nowhere near as overvalued (on any metric you care to use) as it was at the start of December 2021. The Nasdaq was at 9150 Jan 2020, down to 7700 on the 1st March 2020 due to Covid. Rates were however very low, inflation muted. A great deal of uncertainty. Everyone made an assumption based on a few months of experience that technology would benefit and the Nasdaq went up to 15,644 at the start of December 2021. Then war, interest rate expectations, inflation. Very different. The Nasdaq is around 10,800 still significantly above where it was pre-covid. Some companies benefitted from Covid - Peloton, Zoom, Moderna etc. Some of those have now come back down to earth somewhat - that's precisely why we have had Cazoo, Deliveroo, Just Eat, Ui Path, Trustpilot sky rocketing then falling back to earth - there are a lot more examples I know. Overall there are not so many companies that will realise an ongoing Covid benefit - maybe Microsoft, local businesses (coffee shops etc) with WFH, vaccine makers etc. But much has changed - a lot of other companies will lose out - transport into cities, city based services to staff no longer in the office full time etc. The Nasdaq however is roughly 20% above where it was pre-Covid in January 2020 when all looked well, low rates for the forseeable future, inflation under control and no war and sky high energy costs. Very different at present. One could argue that Covid caused a temporary (unjustified blip in many technology valuations as investors ran scared from airlines, hotels, travel, leisure, manufacturing etc to the only sanctuary they saw - technology. It could be a long road back to those sorts of valuations - if ever. Some companies will globally lead but there will be only a few Amazons, Googles, Apples and Metas along that road. A lot will also be the Yahoos, Ciscos (still not back to where it was 20 years or so ago), Wirecards, Pelotons, Theranos etc. Really dangerous to hang on or anchor to prior share price levels - they aren't really relevant now. Broadly markets will oscillate between despair (we aren't there in my view- there isn't real fear as such) and exuberance (we were likely there with things like Cazoo at the valuation it IPO'd at!